AzTrials
AzTrials

Post Operative PainNCT05179928

Erector Spinae Plane Block Versus Rectus Sheath Block for Postoperative Analgesia After Supraumbilical Surgery

A study testing Erector Spinae Plane Block (ESPB) and Rectus Sheath Block (RSB) in people with Post Operative Pain, run by Damanhour Teaching Hospital at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Objectives: To compare the effectiveness of erector spinae plane block (ESPB) and rectus sheath block (RSB) in providing postoperative analgesia after supraumbilical surgery in adult patients and their impact on the patient's outcomes. Read more about this study

Who is it for?
Ages 21 to 60 years
Conditions the study is for
Post Operative Pain
What is being tested?
Erector Spinae Plane Block (ESPB) and Rectus Sheath Block (RSB)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
1 Aug 2026to 1 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • American Society of Anesthesiologists (ASA) physical status ≤ II
  • Age from 21 to 60 years
  • Body Mass Index (BMI) < 35 kg/m²

Who cannot join

  • American Society of Anesthesiologists (ASA) physical status > II
  • Age < 21 years or > 60 years
  • Body Mass Index (BMI) ≥ 35
  • Local infection at the puncture site
  • Altered mental status
  • Pregnant women
Show all 10Show fewer
  • Allergy to study drugs
  • Chronic pain
  • Coagulation abnormalities or on anticoagulants
  • Severe hepatic or kidney disease

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ahmed M Shaat, MD contact

00201223482709

ahmedshaat99@gmail.com

Egypt1 site, 1 recruiting
  • Damanhour Teaching Hospital

    Damanhūr, El-Beheira

    Ahmed M Shaat, MD, 00201223482709, ahmedshaat99@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Is Erector Spinae Plane Block More Effective Than Rectus Sheath Block for Postoperative Analgesia After Supraumbilical Surgery in Adult Patients

Objectives: To compare the effectiveness of erector spinae plane block (ESPB) and rectus sheath block (RSB) in providing postoperative analgesia after supraumbilical surgery in adult patients and their impact on the patient's outcomes.

Background: Supraumbilical surgery for hernia repair is the second-most-popular after surgical inguinal hernia repair and is accompanied by moderate to severe postoperative pain, so patients always require large doses of opioids within the first postoperative day. Because opioids have several adverse effects such as drowsiness, pruritus, nausea, and vomiting, regional analgesic techniques are an essential component of postoperative opioid-sparing analgesia. Previous studies have shown that regional analgesic techniques after abdominal wall surgeries can be an essential element of a postoperative pain management strategy with minimal adverse effects and hemodynamic responses.

Read more

ESPB provides both somatic and visceral analgesia to the abdominal wall, through the blockade of the anterior rami of spinal nerves and the rami communicants involving sympathetic nerve fibers. RSB provides analgesia to the anterior abdominal wall from the xiphoid process to the symphysis pubis, through the blockade of the anterior rami of the 7th to 12th intercostal nerves. The dermatomal distribution of ESPB and RSB makes them ideal regional analgesic techniques after abdominal surgery, and to our knowledge, there were no previous trials that studied the difference between them.

Patients and Methods: This was a prospective, randomized (1:1), double-blind clinical trial on 60 patients scheduled for elective supraumbilical surgery under general anesthesia at our hospital. Patients will be randomly allocated into two equal groups (30 patients each) and will receive: in group E; general anesthesia with postoperative bilateral ultrasound-guided ESPB, whereas in group R; general anesthesia with postoperative bilateral ultrasound-guided RSB.

Being tested
Erector Spinae Plane Block (ESPB), Rectus Sheath Block (RSB)
Keywords
Erector Spinae Plane Block, Rectus Sheath Block, Regional Analgesia
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Erector Spinae Plane Block (ESPB)Procedure or surgery

    Postoperative Bilateral Ultrasound-guided ESPB

  • Rectus Sheath Block (RSB)Procedure or surgery

    Postoperative Bilateral Ultrasound-guided RSB

Study groups in NCT05179928
Study groupRoleWhat they receive
Group E (n=30)Active comparatorErector Spinae Plane Block
Receives: Procedure: Erector Spinae Plane Block (ESPB)
Group R (n=30)Active comparatorRectus Sheath Block
Receives: Procedure: Rectus Sheath Block (RSB)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean and Standard deviation of time to the first request of postoperative rescue analgesic (minutes) (mean±SD)

    The time interval between the block performance and the first request of postoperative analgesia

    Measured: 24 hours after block performance

Secondary outcomes (3)
  1. Mean and Standard deviation of Numeric Pain Rating Scale (NPRS) score (mean±SD)

    NPRS measures the severity of postoperative pain, it is a 11 point scale from 0-10; where 0=No pain and 10=Worst possible pain (30 minutes, 1h, 6h, 12h, 18h, 24h) after block performance

    Measured: 24 hours after block performance

  2. Mean and Standard deviation of the total dose of the rescue analgesic consumed (milligrams) (mean±SD)

    The total dose of the rescue analgesic consumed in the first 24 hours after block performance

    Measured: 24 hours after block performance

  3. Number of participants and Rate of Postoperative Complications

    Number of participants and Rate of: Nausea, Vomiting, Hematoma formation, Bowel perforation, and Pneumothorax

    Measured: 24 hours after block performance

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2022
  2. Study start1 Aug 2026
  3. Primary completion15 Feb 2027 (estimated)
  4. Study completion1 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05179928
Sponsor's protocol ID
DTH: 21004
Status last verified
Jul 2026
First submitted
17 Dec 2021
Last updated
21 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Erector Spinae Plane Block (ESPB) and Rectus Sheath Block (RSB) in people with Post Operative Pain, run by Damanhour Teaching Hospital at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ahmed M Shaat, MD (00201223482709, ahmedshaat99@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean and Standard deviation of time to the first request of postoperative rescue analgesic (minutes) (mean±SD) (time frame: 24 hours after block performance). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in